miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma

Published:2019-03 Issue:3 Volume:27 Page:559-570
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Xu Jian,Su Yan,Xu Aoshuang,Fan Fengjuan,Mu Shidai,Chen Lei,Chu Zhangbo,Zhang Bo,Huang Haifan,Zhang Jiasi,Deng Jun,Ai Lisha,Sun Chunyan,Hu Yu

Funder

National Natural Science Foundation of China

Clinical Research Physician Program of Tongji Medical College, HUST

Key Project of Hubei Provincial Natural Science Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology;Kumar;J. Natl. Compr. Canc. Netw.,2017

2. Multiple myeloma;Palumbo;N. Engl. J. Med.,2011

3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

4. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study;Kumar;Leukemia,2012

5. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma;Richardson;N. Engl. J. Med.,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy;Medical Oncology;2024-06-07

2. Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors;International Journal of Nanomedicine;2024-01

3. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance;Comprehensive Hematology and Stem Cell Research;2024

4. Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma;Non-Coding RNA;2023-11-03

5. IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myeloma;Haematologica;2023-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3